SIRIAMLAB

Controlled document PF-022A

InflammaSacra III Master Formula

TemplateDocumented

Record identification

Document ID
PF-022A
Document type
Template
Status
Documented
Source
Standardisation & Production of SIRIAM Products

Overview

PF-022A

PRODUCT FORMULA CARD

SIRIAM INFLAMMASACRA III

INTEGRALIS

Long-term Neuroconnective Integration

DOCUMENT CONTROL

Field

Product ID

Formula ID

Document

Product

Family

Therapeutic Phase

Clinical Stage

Version

ValueSIR-INF-003
ValueMF-022
ValuePF-022A
ValueInflammaSacra III
ValueInflammaSacra™
ValueINTEGRALIS
Value> 3 months
Value2.0

1. PRODUCT PURPOSE

Field

Clinical Objective

Primary Biological Target

Clinical Stage

Therapeutic Phase

The magistral fiche defines this phase as chronic neurodermal and vegetative integration focused on restoring cellular memory, fascial stability and autonomic balance.

DescriptionLong-term neurodermal and autonomic stabilisation
DescriptionCellular memory, fascial stability and neurovegetative coherence
DescriptionChronic (>3 months)
DescriptionINTEGRALIS

2. MASTER FORMULA

(Current → Proposed layout)

CodeIngredient
CodeCurrent
CodeProposed
CodeUnit
CodePC-001
CodeLanette Cream FNA
Code67.00
Codeg
CodePC-002
CodeAqua Purificata
Code16.00
Codeg
CodeSC-001
CodeMagnesium Chloride
Code2.00
Codeg
CodeSC-002
CodeMSM
Code1.00
Codeg
CodeAC-003
CodePEA
Code0.50
Codeg
CodeAC-005
CodeNiacinamide
Code1.00
Codeg
CodeSC-003
CodeD-Panthenol
Code1.20
Codeg
CodeSC-004
CodeVitamin E Full Spectrum
Code0.70
Codeg
CodeAC-010
CodeQuercetin
Code0.50
Codeg
CodeAC-011
CodeZinc Bisglycinate
Code0.50
Codeg
CodeBE-001
CodeBoswellia serrata
Code0.30
Codeg
CodeBE-004

Related documents